[Liraglutide and glimepiride on glycaemic control in type 2 diabetes in the Mexican cohort (LEAD 3)].
医学
妇科
作者
Pedro Alberto García-Hernández,María del Rosario Arechavaleta-Granell,Jorge Yamamoto,A Falahati,Guillermo González-Gálvez,Grupo de Investigadores de Lead en México
出处
期刊:PubMed [National Institutes of Health] 日期:2011-02-24卷期号:48 (5): 543-8被引量:2
in Mexican subjects with DM2, liraglutide monotherapy can provide greater reduction in HbA1c, weight loss and lower risk of hypoglycaemia in comparison with glimepiride.